Acumen Research and Consulting recently published report titled “Biotechnology Market Market Share, Analysis Report and Region Forecast, 2022 – 2030”
LOS ANGELES , Sept. 20, 2022 (GLOBE NEWSWIRE) — The Global Biotechnology Market Size accounted for USD 372.8 Billion in 2021 and is estimated to achieve a market size of USD 1,345.0 Billion by 2030 growing at a CAGR of 15.5% from 2022 to 2030.
Biotechnology Market Report Key Highlights
Global biotechnology market value was worth USD 372.8 billion in 2021, with a 15.5% CAGR from 2022 to 2030
North America biotechnology market dominates with more than 44% market share in 2021
According to research, the bio-informatics is expected to grow at rapid pace of 21% during the forecast period
Among applications, the health sector hit 50% market share in 2021
Rising demand for organics medicines and drugs, are drives the biotechnology market
Request For Free Sample Report @ https://www.acumenresearchandconsulting.com/request-sample/2591
Report Coverage:
Market
Biotechnology Market
Biotechnology Market Size 2021
USD 372.8 Billion
Biotechnology Market Forecast 2030
USD 1,345.0 Billion
Biotechnology Market CAGR During 2022 – 2030
15.5%
Biotechnology Market Analysis Period
2018 – 2030
Biotechnology Market Base Year
2021
Biotechnology Market Forecast Data
2022 – 2030
Segments Covered
By Technology, By Application, And By Geography
Biotechnology Market Regional Scope
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Key Companies Profiled
AstraZeneca plc, Gilead Sciences, Inc., Celgene Corporation, Biogen Inc., Abbott Laboratories, Amgen Inc., Novo Nordisk A/S, Merck & Co., Inc., Johnson & Johnson Services, Inc., and Novartis AG.
Report Coverage
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis
Biotechnology is ideally positioned to substitute more sustainable biological alternatives for harmful materials and chemical processes. This scientific subject is based on thousands of years of evolution in which living creatures have specialized in the production and recycling of various materials and chemicals. These biological mechanisms have the potential to break down waste more efficiently and produce materials with fewer pollutants, land, water, and energy use than the conventional approach.
Biotechnology permits the industrial production of a wide range of products by utilizing various microorganisms as well as organic metabolic functions. Historically, these naturally occurring substances were either not utilized at all or were only employed by a few businesses. Meanwhile, as of today, a variety of sectors have begun to adopt these products to meet a variety of environmental criteria, which is projected to fuel the biotechnology market share over the projection period.
Global Biotechnology Market Dynamics
Biotechnology Is Reshaping the Healthcare Industry
Growing chronic illness prevalence and the introduction of novel treatments are propelling the biotechnology market revenue growth. Biotechnology is extremely advantageous in the treatment of various ailments. From the point at which antibiotic-producing bacteria are cultured in a fermentation medium to the point at which a pure antimicrobial product is obtained, the pharmaceutical business employs biotechnology procedures. Furthermore, the use of current biotechnology can enhance the effectiveness of a variety of disease-specific innovative therapeutic techniques. Biotechnology is crucial in the healthcare system. Biotechnology is extensively used in the production of different medications and vaccinations used to cure various diseases. Biotechnology is used in a variety of additional medical treatments that play key roles in the public health system.
Check the detailed table of contents of the report @
https://www.acumenresearchandconsulting.com/table-of-content/biotechnology-market
Biotechnology Market Segmentation
The global biotechnology market has been segmented by Acumen Research and Consulting based on technology, and application. By technology, the market is separated into nanobiotechnology, dna sequencing, fermentation, chromatography, tissue engineering and regeneration, cell-based assays, PCR technology, and others. In terms of technology, the others segment is predicted to dominate in the coming years. In contrast, DNA sequencing had the second-largest market position in 2021. The segment’s expansion can be attributed to the increasing use of advanced DNA sequencing. For example, in April 2020, the Baylor University of Medicine Human Genome Sequencing Center (BCM-HGSC) was awarded a National Institutes of Health grant for a Pacific Biosciences Sequel II DNA sequencing instrument. It will help to improve sequencing capacity and efficiency. The new arpeggiator can navigate tough regions of the genetic code, allowing for full genome sequencing.
In terms of the application, the segment is divided into health, natural resources & environment, bioinformatics, food & agriculture, industrial processing, and others. According to the biotechnology market forecast, the health segment is expected to dominate the market during the forecast period. The rising prevalence of chronic diseases is primarily to blame for the segment’s expansion. Furthermore, the adoption rates of bioinformatics strategies, as well as a thriving bio-industrial sector, are all contributing to providing lucrative opportunities for segment growth.
Global Biotechnology Market Regional Outlook
The global biotechnology market is divided into several geographic regions: North America, Asia-Pacific, Latin America, Europe, and the Middle East and Africa. According to biotechnology industry analysis, North America is projected to account for the prevalent portion of the global market in 2021. The presence of significant players, comprehensive R&D activities, and elevated healthcare expenditure all make a significant contribution to the growth of the regional market. Moreover, an increasing number of businesses that operate in the region are obtaining drug authorizations, which is helping to drive the biotechnology market growth. For example, Biogen Inc. received FDA approval for PLEGRIDY (peginterferon beta-1a) in February 2021, which is used to treat relapsing forms of multiple sclerosis. The approval adds to the industry’s main portfolio of multiple sclerosis treatments.
In contrast, Asia-Pacific is predicted to have the fastest rising CAGR in the coming years. The expansion of the regional market is primarily due to an enhanced healthcare system, favorable government policies, clinical study assistance, and epidemiologic study factors. Moreover, foreign firms are strongly working in collaboration with local firms to speed up the biotechnology industry’s growth. Such factors are contributing to the global biotechnology market trend.
Buy this premium research report –
https://www.acumenresearchandconsulting.com/buy-now/0/2591
Biotechnology Market Players
Some of the prominent biotechnology market companies are AstraZeneca plc, Celgene Corporation, Abbott Laboratories, Novo Nordisk A/S, Johnson & Johnson Services, Inc., Biogen Inc., Amgen Inc., Merck & Co., Inc., Gilead Sciences, Inc., and Novartis AG.
Some of the key strategies regarding the biotechnology industry include:
In January 2021, Gilead Sciences, Inc. and Vir Biotechnology, Inc. have formed a partnership. The partnership will assess new therapeutic pairing strategies with the goal of constructing a functional remedy for prolonged hepatitis B virus (HBV). The companies intend to begin a Phase 2 trial evaluating standard treatment for both treatment-experienced and treatment-naive HBV patients.
In October 2019, Novo Nordisk A/S has signed a partnership with bluebird bio, Inc. The partnership is working together to develop next-generation in vivo genome engineering treatments for genetic conditions such as hemophilia. Bluebird and Novo Nordisk will collaborate for three years to identify an advancement gene therapy nominee with the goal of offering people with hemophilia a life free of component replacement therapy.
Browse More Research Topic on Healthcare Related:
Global Red Biotechnology Market Size is expected to reach around USD 500 Billion by 2026 and will grow at noteworthy CAGR around 5.6 % throughout the forecast period 2019 to 2026.
The Global Healthcare Laboratory Information Market accounted for USD 1.98 Billion in 2020 with a considerable CAGR of 8.7% during the forecast period of 2021 to 2028.
The Global Biohacking Market is anticipated to grow at a CAGR of around 20.0% during the forecast period 2021 to 2028 and to reach around USD 66.7 Billion by 2028.
About Acumen Research and Consulting:
Acumen Research and Consulting is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact-based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
For Latest Update Follow Us on Twitter and, LinkedIn
Contact Us:
Mr. Richard Johnson
Acumen Research and Consulting
USA: +13474743864
India: +918983225533
E-mail: sales@acumenresearchandconsulting.com
Blue Tiger Advisors Independent Board Member Deborah Byers assesses the forecasts for gas prices, the sentiment from oil drilling companies, European fracking, and concerns surrounding Russian President Putin's power plays in energy markets.
During his testimony to Congress on Wednesday, JPMorgan CEO Jamie Dimon criticized cryptocurrencies like bitcoin, comparing them to Ponzi schemes.
The comments made by CFO Richard Galanti on its conference call suggest the Fed will still be in inflation-fighting mode for the rest of the year
The Public Company Accounting Oversight Board is to determine whether Alibaba, Yum China and other firms can keep their listings on American stock exchanges.
Yahoo Finance Live reports on Ford's outlook for restructuring its global supply chain.
JPMorgan Chase CEO Jamie Dimon assured lawmakers of his commitment to helping finance traditional energy sources.
(Bloomberg) — Volkswagen AG is exploring ways to counter a shortage in natural gas, including shifting production around its network of global facilities, signaling how the energy crisis unleashed by Russia’s invasion of Ukraine threatens to upend Europe’s industrial landscape.Most Read from BloombergJapan to Restore Visa-Free Travel From Oct. 11 as Covid Pandemic Recedes South Korea President Caught on Hot Mic Insulting US CongressUnless Rents Rise, Housing Is Set Up for an Epic CrashA Great C
(Reuters) -U.S. chip designer Qualcomm Inc on Thursday said its automotive business "pipeline" increased to $30 billion, up more than $10 billion since its third quarter results were announced in late July. The jump in future business was thanks to its Snapdragon Digital Chassis product used by car makers and their suppliers, Qualcomm said at its Automotive Investor Day. The Snapdragon Digital Chassis can provide assisted and autonomous driving technology, as well as in-car infotainment and cloud connectivity.
Astra is one step away from a long-sought long-term lease at Alameda Point, where its growth has in some cases moved faster than the city can accommodate.
The company earlier this year raised $385 million in fresh capital.
As many drillers pull back, modest-size APA is on a worldwide hunt for oil and gas. Its stock could jump nearly 90%.
Customers are not thrilled with the state of air travel at the moment. The situation has been so out of control recently that Secretary of Transportation Pete Buttigieg has been threatening to crack down on the industry, demanding that airlines provide meal and hotel vouchers for passengers who face serious delays, and has also announced a proposal that would guarantee that customers would get a refund for a canceled flight or a flight delayed by more than three hours, if they chose not to take a later flight.
Case against former president, three of his children and his company centers on state law that gives the attorney general broad power to address persistent fraud in business.
A South Florida Porsche dealer is suing Porsche Cars North America, alleging that the auto maker's U.S. subsidiary has violated Florida auto dealership laws.
A study that looked at billions of years worth of asteroid craters on the Moon’s surface has concluded that space rock impacts wobbled the moon so much its poles moved.
Vaccine maker Novavax has sunk to a new low for the move down as fundamental analysts are publishing weaker ratings. President Biden's recent assessment of Covid has not helped, either. Let's check the charts and indicators.
Two years in, the chip shortage is still forcing companies to make significant production cutbacks.
Things I learned on TikTok: The hole in a pasta spoon is one serving of spaghetti. A trending TikTok challenge publicizing a technique for stealing certain makes and models of Kia and Hyundai vehicles caused vehicle thefts to soar across the country, according to reports from several police departments. Now, Kia and its parent company Hyundai are getting sued by pissed off victims.
Elizabeth Warren bears down on reimbursing Zelle customers cheated by scammers, while GOP senators push back on banks' liberal social policies.
Deere's brand dominates in the U.S., but not in international markets. That could change drastically over the next decade.